| 232-P Validation of a cytometric bead array (CBA) assay to detect anti-erythropoiesis stimulating agent (ESA) antibodies to support diagnostic testing and pharmacovigilance K Davis, T Barger, D Mytych, S Swanson, T Goletz, D Wrona Human Immunology 1 (72), S161, 2011 | | 2011 |
| A detailed examination of the antibody prevalence and characteristics of anti-ESA antibodies TE Barger, D Wrona, TJ Goletz, DT Mytych Nephrology Dialysis Transplantation 27 (10), 3892-3899, 2012 | 24 | 2012 |
| A MUC1/IL-18 DNA vaccine induces anti-tumor immunity and increased survival in MUC1 transgenic mice LA Snyder, TJ Goletz, GR Gunn, FF Shi, MC Harris, K Cochlin, ... Vaccine 24 (16), 3340-3352, 2006 | 51 | 2006 |
| Alexander-Miller, Martha A., 148 Arciniegas, Enrique, 59 Arrunategui-Correa, Victor, 109 C Asokanathan, LA Babiuk, J Bae, NE Bianco, B Bourassa, MB Browning, ... Cellular Immunology 227, 157, 2004 | | 2004 |
| antagonistas do receptor 3 semelhante a toll, mÉtodos e usos J Carton, M Cunningham, D Anuk, K Duffy, TJ Goletz, DM Knight, R Lamb, ... | | 2008 |
| Anti-drug antibody validation testing and reporting harmonization H Myler, J Pedras-Vasconcelos, K Phillips, CS Hottenstein, ... The AAPS Journal 24, 1-23, 2022 | 30 | 2022 |
| Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine V Bronte, MW Carroll, TJ Goletz, M Wang, WW Overwijk, F Marincola, ... Proceedings of the National Academy of Sciences 94 (7), 3183-3188, 1997 | 195 | 1997 |
| Antigenicity of fusion proteins from sarcoma-associated chromosomal translocations BS Worley, LT Van den Broeke, TJ Goletz, CD Pendleton, EM Daschbach, ... Cancer research 61 (18), 6868-6875, 2001 | 115 | 2001 |
| CD40 ligand/CD40 stimulation regulates the production of IFN-γ from human peripheral blood mononuclear cells in an IL-12-and/or CD28-dependent manner JF McDyer, TJ Goletz, E Thomas, CH June, RA Seder The Journal of Immunology 160 (4), 1701-1707, 1998 | 94 | 1998 |
| Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics D Wullner, L Zhou, E Bramhall, A Kuck, TJ Goletz, S Swanson, ... Clinical immunology 137 (1), 5-14, 2010 | 84 | 2010 |
| Correlation of in silico prediction of immunogenicity of therapeutic proteins with immune responses in clinical studies. V Jawa, D Mytych, M Moxness, D Zhong, S Swanson, N Chirmule, ... The FASEB Journal 22, 563-563, 2008 | | 2008 |
| Delivery of antigens to the MHC class I pathway using bacterial toxins TJ Goletz, KR Klimpel, SH Leppla, JM Keith, JA Berzofsky Human immunology 54 (2), 129-136, 1997 | 92 | 1997 |
| Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy ECC Wong, VE Maher, K Hines, J Lee, CS Carter, T Goletz, W Kopp, ... Cytotherapy 3 (1), 19-29, 2001 | 49 | 2001 |
| Development of a human antibody tolerant mouse model to assess the immunogenicity risk due to aggregated biotherapeutics V Bi, V Jawa, MK Joubert, A Kaliyaperumal, C Eakin, K Richmond, O Pan, ... Journal of pharmaceutical sciences 102 (10), 3545-3555, 2013 | 56 | 2013 |
| Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and … JF McDyer, M Dybul, TJ Goletz, AL Kinter, EK Thomas, JA Berzofsky, ... The Journal of Immunology 162 (6), 3711-3717, 1999 | 73 | 1999 |
| Engineering human IL-18 with increased bioactivity and bioavailability B Swencki-Underwood, MR Cunningham, GA Heavner, C Blasie, ... Cytokine 34 (1-2), 114-124, 2006 | 11 | 2006 |
| Generation of cytotoxic T cells against tumor-specific translocations: Potential anti-cancer vaccines for Ewing's sarcoma and alveolar rhabdomyosarcoma. TJ Goletz, S Zhan, CD Pendleton, LJ Helman, JA Berzofsky FASEB JOURNAL 10 (6), 2521-2521, 1996 | | 1996 |
| Genetic analysis of indefinite division in human cells: Evidence for a common immortalizing mechanism in T and B lymphoid cell lines TJ Goletz, S Robetorye, OM Pereira-Smith Experimental cell research 215 (1), 82-89, 1994 | 12 | 1994 |
| gp100/pmel 17 is a murine tumor rejection antigen: induction of “self”-reactive, tumoricidal T cells using high-affinity, altered peptide ligand WW Overwijk, A Tsung, KR Irvine, MR Parkhurst, TJ Goletz, K Tsung, ... The Journal of experimental medicine 188 (2), 277-286, 1998 | 596 | 1998 |
| gp100/pmel 17 Is a Murine Tumor Rejection Antigen: Induction of “Self”-reactive, Tumoricidal T Cells Using High-affinity, Altered Peptide Ligand W Willem, MR Parkhurst, TJ Goletz, K Tsung, MW Carroll, C Liu, B Moss The Journal of Experimental Medicine 188 (2), 277-286, 1998 | 1 | 1998 |
